EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prevalence of viral hepatitis B markers among blood donors in the Republic of Guinea

S Boumbaly, T A L Balde, A V Semenov, Yu V Ostankova, E N Serikova, E V Naidenova, D E Valutite, A N Shchemelev, E B Zueva, E V Esaulenko, Areg A Totolian

Problems of Virology · 15.03.2022 · 67 (1) · 59-68

DOI: 10.36233/0507-4088-92 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Problems of Virology, online erschienen am 15.03.2022. Verfasst von S Boumbaly und 10 weiteren Autor:innen. Beteiligte Einrichtung: International Tropical Infections Research Center; Research Institute of Applied Biology of Guinea. Hauptthemen laut MEDLINE: Hepatitis B, Hepatitis B, Chronic. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The problem of transfusion safety in relation to parenteral viral hepatitis still remains relevant. Viral hepatitis B (HB) remains the most common viral infection transmitted through transfusion procedures. One of the natural phases of chronic hepatitis B (CHB) is occult hepatitis B infection (OBI), characterized by an undetectable HBsAg (regardless of the other serological markers content) in the presence of hepatitis B virus (HBV) DNA in the liver tissue and an extremely low, up to undetectable, level of viral load in the blood. In the Republic of Guinea, as in most countries on the continent, the prevention of HBV transmission through transfusion is still based on HBsAg serological testing of donors only. In this connection, OBI remains as a potential threat to blood transfusion safety. Detection of HBV DNA is a reliable preventive measure against transmission of the virus from donors with HBsAg-negative HBV infection, especially in highly endemic regions. In this regard, the study was conducted to substantiate recommendations for improving blood safety against the background of significant HBV prevalence in the Republic of Guinea.The aim of the work was the evaluation of serological and molecular markers of HBV infection in blood donors in the Republic of Guinea.Material and methods. We examined 250 blood samples obtained from donors living in Conakry, Republic of Guinea. Samples were tested for the presence of serological (surface antigen, HBsAg; antibodies (ABs) to surface (anti-HBs IgG) and core (anti-HBc IgG) antigens) and molecular (DNA) markers of HBV infection.Results and discussion. The overall detection rate of hepatitis B markers was 83.2%; HBsAg was detected in 16.4% of all individuals. The high incidence of HBsAg in men (19.55%) compared to women (8.45%) was shown, the relative risk of HBV infection with the formation of HBsAg-positive chronic hepatitis B in males was also significantly higher. The prevalence of the HBV DNA in the study group was 30.4%, the OBI cases accounted for 15.6%. The prevalence of this form of the disease was shown in donors aged 30–49 years (24.78%), in the group of people younger than 30 years, the incidence was lower (8.73%), and at the age of over 50 years, OBI was not detected. Based on the phylogenetic analysis of 76 virus isolates, it was shown that genotype E prevails in the examined group (85.53%).Cases of pathogen DNA detection occurred in HBsAg-negative blood donors in the presence of anti-HBs IgG (n = 4), as well as in the simultaneous presence of ABs anti-HBs IgG and anti-HBc IgG (n = 7). The viral load exceeded 200 IU/ml in OBI samples. Escape mutations were detected by sequencing in each OBI sample, contributing to the virus escaping from diagnostic based on screening for HBsAg.

Conclusion

Assessment of the prevalence viral hepatitis B markers in blood donors, determination of genotypes and clinically significant mutations of virus variants are necessary to ensure safe medical manipulations, control and prevention of the spread of this infectious agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis BHepatitis B, ChronicBiomarkersBlood DonorsDNA, ViralFemaleGuineaHepatitis B Core AntigensHepatitis B Surface AntigensHepatitis B virusHumansImmunoglobulin GMalePhylogenyPrevalence

Substanzen

BiomarkersDNA, ViralHepatitis B Core AntigensHepatitis B Surface AntigensImmunoglobulin G

Autor:innen und Institutionen

  • International Tropical Infections Research Center; Research Institute of Applied Biology of Guinea.
  • Research Institute of Applied Biology of Guinea.
  • FSBI State Scientific Center of Virology and Biotechnology «Vector» of the Federal Service for Surveillance of Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor).
  • FBSI «Saint Petersburg Pasteur Research Institute of Epidemiology and Mictobiology» of the Federal Service for Surveillance of Consumer Rights Protection and Human Welfare (Rospotrebnadzor).
  • FSHI Russian Research Anti-Plague Institute «Microbe» of the Federal Service for Surveillance of Consumer Rights Protection and Human Welfare (Rospotrebnadzor).

Zitieren

APA

Boumbaly, S., Balde, T. A. L., Semenov, A. V., Ostankova, Y. V., Serikova, E. N., Naidenova, E. V., Valutite, D. E., Shchemelev, A. N., Zueva, E. B., Esaulenko, E. V., & Totolian, A. A. (2022). Prevalence of viral hepatitis B markers among blood donors in the Republic of Guinea. Problems of Virology, 67(1), 59-68. https://doi.org/10.36233/0507-4088-92

Vancouver

Boumbaly S, Balde TAL, Semenov AV, Ostankova YV, Serikova EN, Naidenova EV, et al. Prevalence of viral hepatitis B markers among blood donors in the Republic of Guinea. Problems of Virology. 2022;67(1):59-68. doi:10.36233/0507-4088-92

BibTeX
@article{Boumbaly2022,
  author = {Boumbaly, S and Balde, T A L and Semenov, A V and Ostankova, Yu V and Serikova, E N and Naidenova, E V and Valutite, D E and Shchemelev, A N and Zueva, E B and Esaulenko, E V and Totolian, Areg A},
  title = {Prevalence of viral hepatitis B markers among blood donors in the Republic of Guinea},
  journal = {Problems of Virology},
  year = {2022},
  volume = {67},
  number = {1},
  pages = {59--68},
  doi = {10.36233/0507-4088-92}
}
Kostenlos starten →